The latest announcement is out from Jiangsu Recbio Technology Co., Ltd. Class H ( ($HK:2179) ). Jiangsu Recbio Technology Co., Ltd. has received ...

A new injectable vaccine to protect dogs aged 8 weeks and older against kennel cough ( Bordetella bronchiseptica) is now ...

"If you can unlock triple digit titers this is the real game that's needed to achieve competitive pricing and profitability" ...

Key market opportunities in the shingles vaccine sector include rising elderly populations; expanding healthcare ...

The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has sought major ...

Ted Jin, founder and CEO of AuX Labs, is leading a charge in the food technology space with a mission driven by global impact ...

GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 c ...

Parkinson’s disease (PD) remains one of the most challenging neurodegenerative disorders to diagnose and monitor.

Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable quantification of His-tagged proteins -- Broadens Amperia's applications across recombinant protein research ...

CompletedstrategicpivotfromR&Dfocustocommercial focusRebranded as Dyadic Applied BioSolutions and launched redesigned website to optimize ...

Entered into an exclusive license agreement with Dynavax for the Company’s COVID-19 oral pill vaccine candidate for potential cumulative proceeds ...